The Company and subsidiaries provides oxygen, respiratory therapy services, infusion therapy services and home medical equipment such as hospital beds, wheelchairs and other medical supplies to the home health care market.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
There is a lot to like about Lincare. Return on equity is above average for the industry at about 19% as of today (3/1/07). Profit margins are over triple the average for this sector. Plus, they have been reducing shares rather than diluting...a welcome bonus. The annual growth rate is a respectable 13% over the last five years. They have been effective at wisely investing retained earnings instead of frittering the money away. Best of all, shares are available at this time for less than 60% of intrinsic value. Oh yes, did I forget to mention a PEG of .9 and return on invested capital of over 15%?